Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aspire In Vitro Maturation Study

NCT: NCT07789730 · ENROLLING_BY_INVITATION

NCT IDNCT07789730
StatusENROLLING_BY_INVITATION
Start Date2026-08-26
Completion2028-02
SponsorInception Fertility Research Institute, LLC (INDUSTRY)
First posted
Last updated

Brief Summary

A study to assess the Capacitation - in-vitro maturation (CAPA-IVM) system as an option for patients with a good ovarian reserve to achieve pregnancy.

Frequently Asked Questions

What is Aspire In Vitro Maturation Study?

Aspire In Vitro Maturation Study is a clinical trial registered under NCT07789730. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07789730?

The current status of NCT07789730 (Aspire In Vitro Maturation Study) is: ENROLLING_BY_INVITATION.

When did Aspire In Vitro Maturation Study start?

Aspire In Vitro Maturation Study started on 2026-08-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.